![Katherine Cohen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Katherine Cohen is the founder of two companies.
She founded HOOKIPA Pharma, Inc. in 2011 and Hookipa Biotech AG in 2011.
At Hookipa Biotech AG, she held the title of Chief Executive Officer from 2011 to 2016.
Dr. Cohen also worked at Intercell AG from 1999 to 2010, where she held the title of SVP, Global Head Corporate & Business Development in 2010.
Dr. Cohen received her undergraduate, graduate, and doctorate degrees from City University of New York.
Anciens postes connus de Katherine Cohen
Sociétés | Poste | Fin |
---|---|---|
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Directeur Général | 20/06/2016 |
Intercell AG
![]() Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | 01/01/2010 |
HOOKIPA PHARMA INC. | Fondateur | - |
Formation de Katherine Cohen
City University of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
HOOKIPA PHARMA INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Health Technology |
Intercell AG
![]() Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |